4Reiaer AP, Kumar PN, Schwartz SM, et al. Genetic variants of platelet glycoprotena receptors and risk of stroke na young women. Stroke,2000, 31 : 1628 - 1633.
5Sonoda A, Murata M, Ito D, et al. Association between platelet glycoproteio Ibaipha genotype and ischemic cerebrovascular disease.Stroke, 2000, 31:493 -497.
6pasche B, Ouknet H, Francis S, et al. Structural changes in platelet glycoprotena IIb/IIIa by ptasmin: determhants and fimctional consequences. Blood, 1994, 83:404 -414.
7Bonnefoy A, Hantgan R, Legrand C, et al. A model of platelet aggregation iavolving multiple nateractions of thrombospondha-1, fibrinogen,and GPIIbIIIa receptor. J Biol Chem, 2001,276:5605 -5612.
8Belniak-Legiec E, Steknasiak Z. Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease-evaluation usnag flow cytometry methods. Neurol Neurochir Pol, 2000, 34:853 -864.
9Wang C, Mody M, Herst R. Flow cytometric analysis of platelet function m stored platelet concentrates. Transfus Sci, 1999, 20:129 - 139.
10Llinas R, Caplan LR. Evidence-based treatment of patients with ischemic cerebrovascular disease. Nenrol Clkt, 2001, 19:79 - 105.
